{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:02:14Z","timestamp":1740106934238,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T00:00:00Z","timestamp":1588550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T00:00:00Z","timestamp":1588550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s00277-020-04047-w","type":"journal-article","created":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T02:02:22Z","timestamp":1588557742000},"page":"1209-1215","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Red blood cell consumption in a large cohort of patients with thalassaemia: a retrospective analysis of main predictors"],"prefix":"10.1007","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7361-3308","authenticated-orcid":false,"given":"Paolo","family":"Ricchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Meloni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Costantini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Spasiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Cinque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biagio","family":"Gargiulo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Pepe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldo","family":"Filosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,4]]},"reference":[{"issue":"3","key":"4047_CR1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1365-2141.1995.tb08351.x","volume":"89","author":"M Cazzola","year":"1995","unstructured":"Cazzola M, De Stefano P, Ponchio L, Locatelli F, Beguin Y, Dessi C, Barella S, Cao A, Galanello R (1995) Relationship between transfusion regimen and suppression of erythropoiesis in beta-thalassaemia major. Br J Haematol 89(3):473\u2013478","journal-title":"Br J Haematol"},{"key":"4047_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1750-1172-5-11","volume":"5","author":"R Galanello","year":"2010","unstructured":"Galanello R, Origa R (2010) Beta-thalassemia. Orphanet J Rare Dis 5:11","journal-title":"Orphanet J Rare Dis"},{"key":"4047_CR3","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2147\/JBM.S61540","volume":"7","author":"K Bayanzay","year":"2016","unstructured":"Bayanzay K, Alzoebie L (2016) Reducing the iron burden and improving survival in transfusion-dependent thalassemia patients: current perspectives. J Blood Med 7:159\u2013169","journal-title":"J Blood Med"},{"issue":"6","key":"4047_CR4","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3324\/haematol.2012.066845","volume":"98","author":"KM Musallam","year":"2013","unstructured":"Musallam KM, Rivella S, Vichinsky E, Rachmilewitz EA (2013) Non-transfusion-dependent thalassemias. Haematologica 98(6):833\u2013844","journal-title":"Haematologica"},{"key":"4047_CR5","volume-title":"Guidelines for the management of non transfusion dependent thalassaemia (NTDT) [Internet]","author":"A Taher","year":"2013","unstructured":"Taher A, Vichinsky E, Musallam K, Cappellini MD, Viprakasit V (2013) Guidelines for the management of non transfusion dependent thalassaemia (NTDT) [Internet]. Thalassaemia International Federation, Nicosia, Cyprus"},{"key":"4047_CR6","volume-title":"Guidelines for the management of transfusion dependent thalassaemia (TDT) [Internet]","author":"MD Cappellini","year":"2014","unstructured":"Cappellini MD, Cohen A, Porter J, Taher A, Viprakasit V (2014) Guidelines for the management of transfusion dependent thalassaemia (TDT) [Internet], 3rd edn. Thalassaemia International Federation, Nicosia (CY)","edition":"3"},{"issue":"5","key":"4047_CR7","doi-asserted-by":"publisher","first-page":"e121","DOI":"10.1111\/bjh.15948","volume":"186","author":"P Ricchi","year":"2019","unstructured":"Ricchi P, Ammirabile M, Costantini S, Spasiano A, Cinque P, Gargiulo B, Filosa A (2019) Longitudinal trend analysis of serum transferrin receptor-1 level in a cohort of patients affected by non-transfusion dependent thalassaemia. Br J Haematol 186(5):e121\u2013e123","journal-title":"Br J Haematol"},{"issue":"2","key":"4047_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/GIM.0b013e3181cd68ed","volume":"12","author":"A Cao","year":"2010","unstructured":"Cao A, Galanello R (2010) Beta-thalassemia. Genet Med 12(2):61\u201376","journal-title":"Genet Med"},{"issue":"3","key":"4047_CR9","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1600-0609.2008.01195.x","volume":"82","author":"P Ricchi","year":"2009","unstructured":"Ricchi P, Ammirabile M, Spasiano A, Costantini S, Di Matola T, Cinque P, Pagano L, Prossomariti L (2009) Hypocholesterolemia in adult patients with thalassemia: a link with the severity of genotype in thalassemia intermedia patients. Eur J Haematol 82(3):219\u2013222","journal-title":"Eur J Haematol"},{"key":"4047_CR10","doi-asserted-by":"crossref","unstructured":"Quinn GP, Keough MJ (2002) Experimental design and data analysis for biologists. In: Press CU (ed) vol","DOI":"10.1017\/CBO9780511806384"},{"issue":"4","key":"4047_CR11","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.blre.2018.02.001","volume":"32","author":"MD Cappellini","year":"2018","unstructured":"Cappellini MD, Porter JB, Viprakasit V, Taher AT (2018) A paradigm shift on beta-thalassaemia treatment: how will we manage this old disease with new therapies? Blood Rev 32(4):300\u2013311","journal-title":"Blood Rev"},{"issue":"7","key":"4047_CR12","doi-asserted-by":"publisher","first-page":"989","DOI":"10.3324\/haematol.2011.053504","volume":"97","author":"F Danjou","year":"2012","unstructured":"Danjou F, Anni F, Perseu L, Satta S, Dessi C, Lai ME, Fortina P, Devoto M, Galanello R (2012) Genetic modifiers of beta-thalassemia and clinical severity as assessed by age at first transfusion. Haematologica 97(7):989\u2013993","journal-title":"Haematologica"},{"issue":"13","key":"4047_CR13","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1182\/blood-2010-08-300335","volume":"118","author":"EA Rachmilewitz","year":"2011","unstructured":"Rachmilewitz EA, Giardina PJ (2011) How I treat thalassemia. Blood 118(13):3479\u20133488","journal-title":"Blood"},{"issue":"Suppl 1","key":"4047_CR14","first-page":"s124","volume":"12","author":"P Ricchi","year":"2014","unstructured":"Ricchi P, Ammirabile M, Spasiano A, Costantini S, Di Matola T, Pepe A, Cinque P, Pagano L, Casale M, Filosa A, Prossomariti L (2014) Extramedullary haematopoiesis correlates with genotype and absence of cardiac iron overload in polytransfused adults with thalassaemia. Blood Transfus 12(Suppl 1):s124\u2013s130","journal-title":"Blood Transfus"},{"issue":"1","key":"4047_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/ejh.12121","volume":"91","author":"M Casale","year":"2013","unstructured":"Casale M, Cinque P, Ricchi P, Costantini S, Spasiano A, Prossomariti L, Minelli S, Frega V, Filosa A (2013) Effect of splenectomy on iron balance in patients with beta-thalassemia major: a long-term follow-up. Eur J Haematol 91(1):69\u201373","journal-title":"Eur J Haematol"},{"key":"4047_CR16","first-page":"CD010517","volume":"9","author":"A Sharma","year":"2019","unstructured":"Sharma A, Easow Mathew M, Puri L (2019) Splenectomy for people with thalassaemia major or intermedia. Cochrane Database Syst Rev 9:CD010517","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"4047_CR17","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1002\/ajh.24139","volume":"90","author":"P Ricchi","year":"2015","unstructured":"Ricchi P, Meloni A, Spasiano A, Neri MG, Gamberini MR, Cuccia L, Caruso V, Gerardi C, D\u2019Ascola DG, Rosso R, Campisi S, Rizzo M, Terrazzino F, Vangosa AB, Chiodi E, Missere M, Mangione M, Positano V, Pepe A (2015) Extramedullary hematopoiesis is associated with lower cardiac iron loading in chronically transfused thalassemia patients. Am J Hematol 90(11):1008\u20131012","journal-title":"Am J Hematol"},{"issue":"6","key":"4047_CR18","first-page":"538","volume":"14","author":"P Ricchi","year":"2016","unstructured":"Ricchi P, Ammirabile M, Costantini S, Spasiano A, Di Matola T, Verna R, Pepe A, Cinque P, Saporito C, Filosa A, Pagano L (2016) Soluble form of transferrin receptor as a biomarker of overall morbidity in patients with non-transfusion-dependent thalassaemia: a cross-sectional study. Blood Transfus 14(6):538\u2013540","journal-title":"Blood Transfus"},{"key":"4047_CR19","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s00277-017-3057-z","volume":"96","author":"P Ricchi","year":"2017","unstructured":"Ricchi P, Meloni A, Costantini S, Spasiano A, Di Matola T, Pepe A, Cinque P, Filosa A (2017) Soluble form of transferrin receptor-1 level is associated with the age at first diagnosis and the risk of therapeutic intervention and iron overloading in patients with non-transfusion-dependent thalassemia. Ann Hematol 96:1541\u20131546","journal-title":"Ann Hematol"},{"issue":"10","key":"4047_CR20","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.3324\/haematol.2017.170605","volume":"102","author":"MW Garbowski","year":"2017","unstructured":"Garbowski MW, Evans P, Vlachodimitropoulou E, Hider R, Porter JB (2017) Residual erythropoiesis protects against myocardial hemosiderosis in transfusion-dependent thalassemia by lowering labile plasma iron via transient generation of apotransferrin. Haematologica 102(10):1640\u20131649","journal-title":"Haematologica"},{"issue":"16","key":"4047_CR21","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1056\/NEJMoa1705342","volume":"378","author":"AA Thompson","year":"2018","unstructured":"Thompson AA, Walters MC, Kwiatkowski J, Rasko JEJ, Ribeil JA, Hongeng S, Magrin E, Schiller GJ, Payen E, Semeraro M, Moshous D, Lefrere F, Puy H, Bourget P, Magnani A, Caccavelli L, Diana JS, Suarez F, Monpoux F, Brousse V, Poirot C, Brouzes C, Meritet JF, Pondarre C, Beuzard Y, Chretien S, Lefebvre T, Teachey DT, Anurathapan U, Ho PJ, von Kalle C, Kletzel M, Vichinsky E, Soni S, Veres G, Negre O, Ross RW, Davidson D, Petrusich A, Sandler L, Asmal M, Hermine O, De Montalembert M, Hacein-Bey-Abina S, Blanche S, Leboulch P, Cavazzana M (2018) Gene therapy in patients with transfusion-dependent beta-thalassemia. N Engl J Med 378(16):1479\u20131493","journal-title":"N Engl J Med"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-04047-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-020-04047-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-04047-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T23:31:37Z","timestamp":1620084697000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-020-04047-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,4]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["4047"],"URL":"https:\/\/doi.org\/10.1007\/s00277-020-04047-w","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2020,5,4]]},"assertion":[{"value":"21 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study complied with the Declaration of Helsinki. All patients gave written informed consent to the protocol. The study was approved by the Ethics Committee of the Cardarelli-Santobono-Pausilipon Hospital, Napoli, Italy.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"A.P. is the PI of the MIOT project that receives \u201cno-profit support\u201d from industrial sponsorships (Chiesi Farmaceutici S.p.A., ApoPharma Inc. and Bayer). The remaining authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}